Biphasic waveform cardioversion as an alternative to internal cardioversion for atrial fibrillation refractory to conventional monophasic waveform transthoracic shock.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 11741567)

Published in Am J Cardiol on December 15, 2001

Authors

D G Benditt1, N Samniah, D Iskos, K G Lurie, B J Padanilam, S Sakaguchi

Author Affiliations

1: Cardiac Arrhythmia Center, Cardiovascular Division, Department of Medicine, Minneapolis, Minnesota 55455, USA. bendi001@tc.umn.edu

Articles by these authors

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2000) 13.13

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol (1998) 11.26

Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med (1996) 8.54

Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60

Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res (1999) 5.41

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med (1985) 5.31

Clinical features and management of hepatic portal venous gas: four case reports and cumulative review of the literature. Arch Surg (2001) 3.66

Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta (1968) 2.87

A comparison of standard cardiopulmonary resuscitation and active compression-decompression resuscitation for out-of-hospital cardiac arrest. French Active Compression-Decompression Cardiopulmonary Resuscitation Study Group. N Engl J Med (1999) 2.79

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med (1994) 2.71

Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med (1982) 2.52

Effect of chronic administration of propranolol on lipoprotein composition. Metabolism (1976) 2.49

Purification and some properties of progenitor toxins of Clostridium botulinum type B. Infect Immun (1974) 2.48

Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation (1997) 2.36

Active compression-decompression. A new method of cardiopulmonary resuscitation. Cardiopulmonary Resuscitation Working Group. JAMA (1992) 2.26

Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol (2000) 2.24

Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med (1982) 2.11

Rapid bioassay for Clostridium botulinum type-E toxins by intravenous injection into mice. Jpn J Med Sci Biol (1968) 1.88

Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol (1969) 1.87

Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol (1992) 1.84

A mouse prion protein transgene rescues mice deficient for the prion protein gene from purkinje cell degeneration and demyelination. Lab Invest (1999) 1.83

Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol (2001) 1.80

Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation (2000) 1.65

Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit Care Med (1999) 1.53

RIKEN integrated sequence analysis (RISA) system--384-format sequencing pipeline with 384 multicapillary sequencer. Genome Res (2000) 1.50

Comparison of epinephrine with vasopressin on bone marrow blood flow in an animal model of hypovolemic shock and subsequent cardiac arrest. Crit Care Med (2001) 1.46

Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography. Jpn J Med Sci Biol (1974) 1.43

Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans. Int Angiol (1993) 1.40

Intraosseous blood gases during hypothermia: correlation with arterial, mixed venous, and sagittal sinus blood. Crit Care Med (2000) 1.39

cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun (2001) 1.37

Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation (1995) 1.32

Specific changes in human brain after hypoglycemic injury. Stroke (1997) 1.30

Evaluation of standard and active compression-decompression CPR in an acute human model of ventricular fibrillation. Circulation (1994) 1.28

A method for permanent transvenous left ventricular pacing. Pacing Clin Electrophysiol (1998) 1.26

Dissociation of Clostridium botulinum type-E-toxin. Biochem Biophys Res Commun (1967) 1.23

Naturally arising CD25+CD4+ regulatory T cells in tumor immunity. Curr Top Microbiol Immunol (2005) 1.22

Aggressive surgery for carcinoma of the gallbladder. Surgery (1989) 1.20

Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med (1995) 1.20

Delayed ischemic hyperintensity on T1-weighted MRI in the caudoputamen and cerebral cortex of humans after spectacular shrinking deficit. Stroke (1999) 1.19

Alterations of lipid metabolism in mice injected with endotoxin. Microbiol Immunol (1979) 1.18

Inspiratory impedance during active compression-decompression cardiopulmonary resuscitation: a randomized evaluation in patients in cardiac arrest. Circulation (2000) 1.16

Oral toxicities of Clostridium botulinum type E toxins of different forms. Jpn J Med Sci Biol (1974) 1.14

Surgery of the portal vein in resection of cancer of the hepatic hilus. Surgery (1986) 1.13

The beneficial effect of a prostaglandin I2 analog on ischemic rat liver. Transplantation (1991) 1.13

Immunologic and clinical studies on murine experimental autoimmune gastritis induced by neonatal thymectomy. Gastroenterology (1988) 1.12

Cell cycle control by Ca2+ in Saccharomyces cerevisiae. J Biol Chem (1990) 1.12

Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation (2001) 1.12

Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. Am J Pathol (2000) 1.12

Identification of a novel gene encoding a PrP-like protein expressed as chimeric transcripts fused to PrP exon 1/2 in ataxic mouse line with a disrupted PrP gene. Cell Mol Neurobiol (2000) 1.11

Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation. Am J Cardiol (1999) 1.10

Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes. Diabetologia (2004) 1.09

A DBL-homologous region of the yeast CLS4/CDC24 gene product is important for Ca(2+)-modulated bud assembly. Biochem Biophys Res Commun (1991) 1.09

Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J Virol (2000) 1.07

Proceedings: Clostridium botulinum type A, B, E and F 12S toxins. Jpn J Med Sci Biol (1975) 1.06

The urokinase type of plasminogen activator in cancer of digestive tracts. Thromb Res (1988) 1.06

Nonfunctioning islet cell carcinoma presenting bleeding gastric varices and splenomegaly. Jpn J Surg (1984) 1.05

Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells. J Immunol (1994) 1.05

Radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia: results and long-term follow-up. J Am Coll Cardiol (1991) 1.05

Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation (2002) 1.04

Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol (1996) 1.02

Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol (2000) 1.01

Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol (1988) 1.01

Molecular size of Clostridium botulinum type E toxin in "izushi". Jpn J Med Sci Biol (1966) 1.01

Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol (2001) 1.00

Translocation, t(4qminus;13qplus), in three generations resulting in partial trisomy of the long arm of chromosome 4 in the fourth generation. J Med Genet (1974) 1.00

Development of antibody to each component of Clostridium botulinum type E progenitor toxin. Jpn J Med Sci Biol (1973) 0.99

Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart (1996) 0.99

Policing the regulators. Nat Immunol (2001) 0.98

Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope. Europace (2003) 0.97

Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis. Thromb Res (1991) 0.97

Cytokine production profile of splenocytes derived from zymosan A-treated SKG mice developing arthritis. Inflamm Res (2006) 0.97

New method of photosensitizer accumulation for photodynamic therapy in an experimental liver tumor. Lasers Surg Med (1989) 0.97

Virus and autoimmunity: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T cells. J Immunol (1999) 0.97

Improving standard cardiopulmonary resuscitation with an inspiratory impedance threshold valve in a porcine model of cardiac arrest. Anesth Analg (2001) 0.96

Identification and genetic mapping of a homeobox gene to the 4p16.1 region of human chromosome 4. Proc Natl Acad Sci U S A (1992) 0.95

The effects of repeated doses of vasopressin or epinephrine on ventricular fibrillation in a porcine model of prolonged cardiopulmonary resuscitation. Anesth Analg (2000) 0.95

Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case. Oncology (2001) 0.94

Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries. An experimental study. Invest Radiol (1995) 0.94

Selective stripping operation based on Doppler ultrasonic findings for primary varicose veins of the lower extremities. Surgery (1988) 0.94

Purification of Clostridium botulinum type G progenitor toxin. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 0.93

Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J Pharmacol Exp Ther (1985) 0.93

Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet (1997) 0.93

Expression of CD44 in kidney after acute ischemic injury in rats. Am J Physiol Regul Integr Comp Physiol (2000) 0.92

Ageing of the vibratory tissue of human vocal folds. Acta Otolaryngol (1989) 0.92

Comparison of progenitor toxins of nonproteolytic with those of proteolytic Clostridium botulinum Type B. Infect Immun (1976) 0.91

Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia (2005) 0.91

Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation (1981) 0.90

Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent. Cell Mol Neurobiol (2000) 0.88

Female-specific neuroprotection against transient brain ischemia observed in mice devoid of prion protein is abolished by ectopic expression of prion protein-like protein. Neuroscience (2005) 0.88

Influence of hypothalamic and ambient temperatures on sleep in kangaroo rats. Am J Physiol (1979) 0.88

Vasopressin administration in refractory cardiac arrest. Ann Intern Med (1996) 0.88

Effects of bovine fatty acid synthase, stearoyl-coenzyme A desaturase, sterol regulatory element-binding protein 1, and growth hormone gene polymorphisms on fatty acid composition and carcass traits in Japanese Black cattle. J Anim Sci (2010) 0.87

CPR: the P stands for plumber's helper. JAMA (1990) 0.87

Development and disintegration of phragmoplasts in living cultured cells of a GFP::TUA6 transgenic Arabidopsis thaliana plant. Protoplasma (2003) 0.87

Significance of hepatic vein reconstruction in hepatectomy. Surgery (1993) 0.86

Implantable cardioverter defibrillator proarrhythmia: case report and review of the literature. Pacing Clin Electrophysiol (1991) 0.86

Impaired motor coordination in mice lacking prion protein. Cell Mol Neurobiol (1998) 0.86

Left ventricular-based pacing in patients with chronic heart failure: comparison of acute hemodynamic benefits according to underlying heart disease. Eur J Heart Fail (2000) 0.86